Takahiko Nakamura
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Acute Exacerbation of Pre-existing Cancer-Related Pain: An Atypical Presentation of an Amivantamab-Induced Infusion-Related Reaction.
Journal: Internal medicine (Tokyo, Japan)
Published: July 05, 2026
TTF-1 Expression and Efficacy of Platinum and Pemetrexed Plus Pembrolizumab in Advanced Lung Adenocarcinoma.
Journal: Anticancer research
Published: October 08, 2025
A novel respiratory reactance index, frequency-dependent, and for effort-independent assessment of COPD severity using MostGraph.
Journal: Respiratory medicine
Published: October 02, 2025
Severe Drug-Induced Interstitial Lung Disease After Administration of Osimertinib as Adjuvant Treatment for Resected EGFR-Mutated NSCLC: A Case Report.
Journal: JTO clinical and research reports
Published: October 26, 2023
Endoscopic features and clinical course of colorectal carcinoma resected by cold snare polypectomy.
Journal: Journal of gastroenterology and hepatology
Published: December 26, 2022
Endoscopic resection for local residual or recurrent cancer after definitive chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.
Journal: Scientific reports
Published: October 24, 2022
Impact of endoscopic surveillance on mortality of metachronous esophageal and head and neck cancer after esophageal endoscopic resection.
Journal: Journal of gastroenterology and hepatology
Published: June 09, 2022
Indication of emergency colonoscopy after colorectal endoscopic submucosal dissection: A proposal of hematochezia scale.
Journal: Journal of gastroenterology and hepatology
Published: March 30, 2022
Clinical features of superficial esophagus squamous cell carcinoma according to alcohol-degrading enzyme ADH1B and ALDH2 genotypes.
Journal: Journal of gastroenterology
Published: March 02, 2022
A Case of Eosinophilic Gastroenteritis Remission Achieved Steroid-Free With Mepolizumab.
Journal: Gastro hep advances
Published: August 23, 2021
Comparison Between Second- and Third-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as First-line Treatment in Patients With Non-small-cell Lung Cancer: A Retrospective Analysis.
Journal: Anticancer research
Published: June 14, 2021
Last Updated: 09/26/2026